» Articles » PMID: 9099467

Treatment of Restless Legs Syndrome with Gabapentin

Overview
Specialty Pharmacology
Date 1997 Apr 1
PMID 9099467
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Gabapentin is a well tolerated anticonvulsant, structurally related to gamma-aminobutyric acid, with an unknown mechanism of action. Restless legs syndrome (RLS) is a disorder characterized by sensory and motor symptoms in the legs that is best treated with dopaminergic drugs and opiates. In this open-label study, eight patients with RLS were treated with gabapentin. Four of the eight had a beneficial response, three with almost complete resolution of symptoms for up to 6 months. For a disorder that is often difficult to treat, these results are encouraging, and they suggest that a placebo-controlled trial is warranted.

Citing Articles

Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Winkelman J, Berkowski J, DelRosso L, Koo B, Scharf M, Sharon D J Clin Sleep Med. 2024; 21(1):153-199.

PMID: 39324664 PMC: 11701280. DOI: 10.5664/jcsm.11392.


Compromised Dynamic Cerebral Autoregulation in Patients with Restless Legs Syndrome.

Zhang Y, Chen Q, Sun Q, Tang M, Yang Y, Guo Z Nat Sci Sleep. 2024; 16:431-443.

PMID: 38706925 PMC: 11069370. DOI: 10.2147/NSS.S448579.


Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?.

Peckham A, Evoy K, Ochs L, Covvey J Subst Abuse. 2018; 12:1178221818801311.

PMID: 30262984 PMC: 6153543. DOI: 10.1177/1178221818801311.


Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Faulkner M CNS Drugs. 2018; 32(2):149-159.

PMID: 29480463 DOI: 10.1007/s40263-018-0502-z.


Review about gabapentin misuse, interactions, contraindications and side effects.

Quintero G J Exp Pharmacol. 2017; 9:13-21.

PMID: 28223849 PMC: 5308580. DOI: 10.2147/JEP.S124391.